Home › Brain Tumors › Missouri › Cape Girardeau
Brain Tumors clinical trials in Cape Girardeau, MO
3 studies for Brain Tumors are looking for participants at sites in and around Cape Girardeau (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
RecruitingPhase 2
- Saint Francis Medical Center, Cape Girardeau
- Southeast Cancer Center, Cape Girardeau
Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or More Brain Metastases
RecruitingPhase 3
- Saint Francis Medical Center, Cape Girardeau
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
RecruitingPhase 3
- Saint Francis Medical Center, Cape Girardeau
About Brain Tumors
A brain tumor is a growth of abnormal cells in the brain tissue. Learn the types of tumors, symptoms, how they are diagnosed and treatment options.
More about Brain Tumors on MedlinePlus
Brain Tumors trials in other cities
- Houston, TX35 studies
- Boston, MA28 studies
- New York City, NY25 studies
- Washington, DC20 studies
- Los Angeles, CA16 studies
- Miami, FL15 studies
- Durham, NC14 studies
- St. Louis, MO12 studies
- Cleveland, OH11 studies
- Seattle, WA11 studies
- Rochester, MN11 studies
- Baltimore, MD11 studies
Other studies in Cape Girardeau
- Non-Small Cell Lung Cancer9 studies
- Lung Cancer8 studies
- Prostate Cancer7 studies
- Head and Neck Squamous Cell Carcinoma6 studies
- Kidney Cancer (Renal Cell Carcinoma)6 studies
- Hypopharyngeal Cancer5 studies
- Laryngeal Cancer5 studies
- Oral Cancer5 studies
- Bladder Cancer5 studies
- Breast Cancer4 studies
- Colon Cancer4 studies
- Colorectal Cancer4 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.